CV1 A Cost-Utility Analysis of Prophylactic Therapy for Venous Thromboembolism with Dabigatran Etexilate or Enoxaparin

Autor:	K. Mieth, Rafael Alfonso-Cristancho, X. Burbano-Levy, S. Herran, G. Sánchez
Rok vydání:	2011
Předmět:	Cost–utility analysis medicine.medical_specialty business.industry Health Policy medicine Public Health Environmental and Occupational Health Intensive care medicine business Venous thromboembolism Dabigatran medicine.drug
Zdroj:	Value in Health. 14(7)
ISSN:	1098-3015
DOI:	10.1016/j.jval.2011.08.1514
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7c682c36c63cf6da40d48da0dbdb85a Zobrazit plný text záznamu Full Text from ScienceDirect